BALTIMORE--Osiris Therapeutics has entered into a research collaboration with Genetica, of Cold Spring Harbor, NY, that covers the functional genomics of human mesenchymal stem cells, the progenitors of structural and connective tissues. The collaboration will focus on the discovery of genes that control the growth and differentiation of the cells, to identify potential drug development targets. The companies said the venture takes advantage of Osiris's proprietary position in human mesenchymal stem cells and its expertise in cell and gene therapy, as well as of Genetica's novel genomics technology.
Osiris is engaged in research and development for therapeutic products for the regeneration of human structural and connective tissues through the use of the stem cells.